Course Listings: Oncology

All Results (20)
Format: Live Events (0) Online Activities (20)

GI Cancer: Sequential Treatment Planning in the Community Oncology Setting

View Course

Format: Med-IQ Select

Maximum Credits: 1.5

Course Description: Join expert faculty for a 90-minute webcast filmed during a gastrointestinal oncology forum that includes didactic lectures and case-based presentations. This activity is designed to take participants through various decision points to better align clinical factors with treatment decisions in a way that confers optimal patient outcomes throughout the disease…More


Extending Survival for Patients With TNBC: Are You Up to Date on New Treatment Standards?

View Course

Format: PDF Publication

Maximum Credits: 1.0

Course Description: This accredited CME/CE publication reviews current data from late-stage clinical trials on checkpoint-inhibitor use in advanced and metastatic triple negative breast cancer (TNBC). It also identifies immune-related adverse events associated with these treatments, provides strategies to manage such events, and offers patient-monitoring recommendations. These…More


The Frontline Treatment of Peripheral T-Cell Lymphoma: Current and Future Strategies

View Course

Format: Med-IQ Select

Maximum Credits: 0.5

Course Description: This 30-minute accredited CME publication discusses individualizing the first-line treatment of peripheral T-cell lymphoma (PTCL). It examines clinical data and potential implications of novel treatment strategies undergoing evaluation in patients with newly diagnosed PTCL. In addition, brief audio clips provide expert perspectives and observations about PTCL…More


Exploring Treatment Options After Disease Progression in Advanced or Metastatic Gastric/GEJ Adenocarcinoma

View Course

Format: Audiocast

Maximum Credits: 0.25

Course Description: Expert faculty review optimal treatment decisions for a patient with metastatic gastric adenocarcinoma whose disease progressed following systemic chemotherapy.


Frontline Treatment Decisions in Advanced or Metastatic Gastric/GEJ Adenocarcinoma

View Course

Format: Audiocast

Maximum Credits: 0.25

Course Description: In this audiocast, expert faculty explore treatment decisions for a patient with newly diagnosed metastatic gastric adenocarcinoma.


Optimizing the Care of Refractory Metastatic CRC

View Course

Format: Audiocast

Maximum Credits: 0.25

Course Description: In this case-based audiocast, expert faculty review sequential treatment planning for a patient with relapsed metastatic colorectal cancer.


Selecting Therapy in Treatment-Naïve, Advanced HCC

View Course

Format: Audiocast

Maximum Credits: 0.25

Course Description: This case-based audiocast discusses the optimization of initial therapy selection for a patient with advanced hepatocellular carcinoma.


Treatment Decisions in Relapsed/Refractory HCC

View Course

Format: Audiocast

Maximum Credits: 0.25

Course Description: In this case-based audiocast, expert faculty explore the translation of emerging research to clinical practice for a patient with relapsed/refractory hepatocellular carcinoma.


Treatment Planning in Newly Diagnosed Metastatic CRC

View Course

Format: Audiocast

Maximum Credits: 0.25

Course Description: In this case-based audiocast, expert faculty discuss selecting treatment for a patient with metastatic colorectal cancer based on molecular characteristics and primary tumor location.


Weighing Treatment Attributes in DLBCL, FL, and CLL

View Course

Format: Audiocast

Maximum Credits: 0.75

Course Description: Join experts Ian Winchester Flinn, MD, PhD, and Jonathan W. Friedberg, MD, MMSc, in an engaging online, modular education CME activity on important treatment attributes of non-Hodgkin lymphomas, specifically diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). This award-winning e-learning platform will…More


Beyond the Horizon: The Promise of Novel Therapies for Relapsed/Refractory DLBCL

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This accredited CME publication explores emerging treatment strategies for diffuse large B-cell lymphoma (DLBCL), including their mechanisms of action, efficacy data, and safety data; it also discusses novel therapies in clinical development for relapsed/refractory DLBCL. Additionally, expert faculty offer their perspectives on the integration of emerging…More


Recent Advances in the Management of Gaucher Disease Type 3

View Course

Format: Presentation Points

Maximum Credits: 0.5

Course Description: This transcript-based, CME-accredited Presentation Points publication highlights key points from a satellite symposium presented by nationally renowned experts on Gaucher disease type 3 (GD3) Pramod K. Mistry, MD, PhD, FRCP, and Raphael Schiffmann, MD, MHSc, FAAN. Faculty review the diagnostic potential of various investigational GD3 biomarkers and provide…More


ROS1 in the Driver’s Seat: Emerging Science and Evolving Strategies in the Treatment of ROS1-Positive NSCLC

View Course

Format: E-Publication

Maximum Credits: 0.5

Course Description: This publication reviews ROS1 gene fusions as an oncogenic driver of non–small cell lung cancer (NSCLC) and available methods for detecting these rearrangements in patients with advanced NSCLC. Data surrounding emerging tyrosine kinase inhibitors (TKIs) that are effective against ROS1-positive NSCLC are also explored. Additionally, audio clips of faculty are…More


Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the First-Line Treatment of Metastatic Urothelial Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive, case-based activity discusses PD-L1 testing in patients newly diagnosed with metastatic urothelial cancer and focuses on immunotherapeutic treatment options for patients with PD-L1–positive tumors. Links to useful resources are provided to help participants make treatment decisions for the patient, and an expert faculty member offers his…More


Incorporating Immunotherapeutic Advances Into the Clinic: A Case Study in the Treatment of Refractory/Recurrent Advanced or Metastatic Urothelial Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive, case-based activity discusses the integration of immune checkpoint inhibitors into treatment strategies for patients with refractory/recurrent advanced or metastatic UC. Links to useful resources are provided to help participants make treatment decisions for the patient, and an expert faculty member offers his perspective on the latest…More


Combatting Treatment-Naïve, Extensive-Stage SCLC With Novel Immunotherapeutic Strategies

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This accredited publication highlights current evidence regarding the use of immune checkpoint inhibitors (ICIs) in combination with standard chemotherapy for patients with treatment-naïve, extensive-stage small cell lung cancer (ES-SCLC). It also examines the implications of incorporating ICIs into first-line ES-SCLC therapy on clinical management and…More


Understanding the Role of Patient-Reported Outcomes in Oncology

View Course

Format: E-publication

Maximum Credits: 0.5

Course Description: This publication explores how patient-reported outcomes (PROs) can be used to better understand the effects that cancer and cancer treatments have on health outcomes and the overall patient experience. Practical tips and best practices to implementing PROs in a clinic’s workflow are discussed.


Incorporating the Latest Therapeutic Advances and Shared Decision Making Into Clinical Practice

View Course

Format: Audiocast

Maximum Credits: 0.5

Course Description: This 30-minute audiocast discusses the treatment of patients with advanced classical Hodgkin lymphoma (cHL), with a focus on novel therapeutic strategies both in first-line and refractory/relapsed settings. In addition, brief clinical case vignettes are included to illustrate how disease-, treatment-, and patient-related factors affect management decisions.


Optimizing Patient-Centered cHL Care: Prompt Recognition and Management of Adverse Events and Empowering Patients

View Course

Format: Audiocast

Maximum Credits: 0.5

Course Description: This 30-minute audiocast discusses best practices in the management of treatment toxicities in patients with advanced classical Hodgkin lymphoma (cHL), along with strategies to educate and support patients throughout the continuum of care. Brief clinical case vignettes are included to illustrate strategies for monitoring for and managing adverse events.


Decision-IQ: A Case Study in Managing Biochemical Recurrence of Prostate Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this short case-based activity, meet Ed, a 59-year-old man who experiences a biochemical recurrence of prostate cancer. As you move through this activity, read through links to useful resources to help you make clinical management decisions for this patient. In addition, find out how Judd Moul, MD, would manage Ed’s recurrence to help reduce his risk of…More




We recently updated our Privacy Notice and Terms of Use.